N. Kaplan Et Al. , "Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?," Current Pharmaceutical Biotechnology , vol.20, no.6, pp.517-524, 2019
Kaplan, N. Et Al. 2019. Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?. Current Pharmaceutical Biotechnology , vol.20, no.6 , 517-524.
Kaplan, N., Yilmaz, I., Karaarslan, N., Kaya, Y. E., Sirin, D. Y., & Ozbek, H., (2019). Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?. Current Pharmaceutical Biotechnology , vol.20, no.6, 517-524.
Kaplan, Necati Et Al. "Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?," Current Pharmaceutical Biotechnology , vol.20, no.6, 517-524, 2019
Kaplan, Necati Et Al. "Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?." Current Pharmaceutical Biotechnology , vol.20, no.6, pp.517-524, 2019
Kaplan, N. Et Al. (2019) . "Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?." Current Pharmaceutical Biotechnology , vol.20, no.6, pp.517-524.
@article{article, author={Necati Kaplan Et Al. }, title={Does nimodipine, a selective calcium channel blocker, impair chondrocyte proliferation or damage extracellular matrix structures?}, journal={Current Pharmaceutical Biotechnology}, year=2019, pages={517-524} }